Unique Device Identification
   HOME

TheInfoList



OR:

The Unique Device Identification (UDI) System is intended to assign a unique identifier to medical devices within the United States, Europe, China, South Korea, Saudi Arabia and Taiwan. It was signed into law in the US on September 27, 2007, as part of the Food and Drug Administration Amendments Act (Section 226) of 2007.


United States

These harmonized pieces of legislation include language related to the establishment of a Unique Device Identification System. When implemented, the new system will always be in reverse mode : * The label of a device to bear a unique identifier, unless an alternative location is specified by the
U.S. Food and Drug Administration The United States Food and Drug Administration (FDA or US FDA) is a federal agency of the Department of Health and Human Services. The FDA is responsible for protecting and promoting public health through the control and supervision of food ...
(FDA) or unless an exception is made for a particular device or group of devices. * The unique identifier to be able to identify the device through distribution and use * The unique identifier to include the lot or serial number if specified by FDA A national UDI system will create a common vocabulary for reporting and enhance electronic tracking abilities. Currently, analysis of adverse event reports is limited by the fact that the specific devices involved in an incident are often not known with the required degree of specificity. Without a common vocabulary for medical devices, meaningful analysis based on data from existing voluntary systems is problematic. Reliable and consistent identification of medical devices would enable safety surveillance so that the FDA and manufacturers could better identify potential problems or device defects, and improve patient care. The UDI is expected to improve patient safety (in part by helping to identify counterfeit products and by improving the ability of staff to distinguish between devices that are similar in appearance but serve different functions), facilitate and improve the recall process, and create efficiencies within the medical system. In the most basic format, the UDI would be a coded number registered with
standards organization A standards organization, standards body, standards developing organization (SDO), or standards setting organization (SSO) is an organization whose primary function is developing, coordinating, promulgating, revising, amending, reissuing, interpr ...
s, and would incorporate a variety of information, including (but not limited to) the manufacturer of the device, expiry dates, the make and model of the device, and any special attributes that the device may possess. In a medical sense, "device" refers to any product that is not
pharmaceutical A medication (also called medicament, medicine, pharmaceutical drug, medicinal drug or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and re ...
in nature, and while the FDA have been given approval to exempt some devices, Jay Crowely (who was responsible for implementing the UDI requirements in the Act), has expressed an intent to apply the UDI to "everything until somebody gives us good reason not to", (excluding devices which won't need identification). Following the passing of the Act, there were calls for the FDA to publish a timeline for the implementation of the UDI; this was subsequently done. GUDID Submission
The Final Rule on Unique Device Identifiers also mandates medical device manufacturers to make a submission to the FDA's Global Unique Device Identification Database. The submission to the GUDID will include the Primary Device Identifier portion of the UDI as well as associated data attributes about each model or version number of the device. Compliance with the submission component of UDI compliance is phased according to the Class of device. Class III device labelers must submit to the GUDID for all existing products by September 24, 2014. Labelers of Implantable, Life Supporting or Life Sustaining devices must submit to the GUDID by September 24, 2015. Class II labelers must comply with submission guidelines by September 24, 2016, and Class I labelers by September 24, 2018. Submission to the GUDID may be made in one of two methods. The first method utilizes the FDA's GUDID Web Interface, which is meant for low volumes of GUDID submissions. The second method utilizes an HL7 SPL submission and is transmitted to the FDA through an Electronic Submission Gateway account. Once the initial submission is made, labelers of medical devices must update the GUDID submission each time there is a change to the device attributes. While many device attributes may be updated once the device record is published within the GUDID, several attributes cannot be changed and will necessitate the labeler deactivate the existing submission and resubmit using a new Device Identifier.


European Union

The EU acted to adopt UDI and on April 5, 2017, under the Medical Devices Regulation (MDR) and In-vitro Diagnostic Regulation (IVDR), but adoption has been postponed to 2021; see Medical Device Regulation. The timelines for UDI marking of medical devices, direct marking of medical devices, and marking of IVD allow for a staggered introduction. The EU UDI scheme includes the so-called Basic UDI-DI, a regulatory identifier of a device and key to the
EUDAMED Regulation (EU) 2017/745 is a regulation (European Union), regulation of the European Union on the clinical investigation and sale of medical devices for human use. It repeals Directive 93/42/EEC (MDD), which concerns medical devices, and Direct ...
database, that does not appear on the device packaging but has to be listed on the Declaration of Conformity. Devices and packaging are to be marked with a device identifier ("UDI-DI"), identifying manufacturer and product, and a production identifier ("UDI-PI)", consisting of, e.g., the LOT and/or expiration date. Custom-made and investigational devices are exempt from this requirement. The direct marking of reusable devices is also included in the regulation. As of July 2022, the EU has recognized four UDI-DI issuing agencies: GS1 AISBL; Health Industry Business Communications Council (HIBCC); ICCBBA, and Informationsstelle für Arzneispezialitäten (IFA GmbH).COMMISSION IMPLEMENTING DECISION (EU) 2019/939 of 6 June 2019 designating issuing entities designated to operate a system for the assignment of Unique Device Identifiers (UDIs) in the field of medical devices


See also

*
Medical device A medical device is any device intended to be used for medical purposes. Significant potential for hazards are inherent when using a device for medical purposes and thus medical devices must be proved safe and effective with reasonable assura ...
*
Global Medical Device Nomenclature Global Medical Device Nomenclature (GMDN) is a system of internationally agreed generic descriptors used to identify all medical device products. This nomenclature is a naming system for products which include those used for the diagnosis, preventi ...


References

{{reflist


External links


FDA's web site about UDI and the Global UDI Database (GUDID)European Commission site on Medical Device Regulation
Food and Drug Administration Government databases in the United States Healthcare in the United States Identifiers Regulation of medical devices